Vol 71, No 3 (2020)
Clinical vignette
Published online: 2020-06-03
Parathyroid imaging with [99mTc]Tc-MIBI SPECT/CT — unexpected findings of bone marrow involvement of non-Hodgkin’s lymphoma
1
, 1
, 1
Abstract
Not required for Clinical Vignette.
Keywords: MIBInon-Hodgkin’s lymphomasmall B-cell lymphomabone marrow
References
- Ohta M, Isobe K, Kuyama J, et al. Clinical role of Tc-99m-MIBI scintigraphy in non-Hodgkin's lymphoma. Oncol Rep. 2001; 8(4): 841–845.
- Fujii H, Nakamura K, Kubo A, et al. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer. Anticancer Res. 1998; 18(6B): 4601–4605.
- Lazarowski A, Dupont J, Fernández J, et al. 99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response. Lymphat Res Biol. 2006; 4(1): 23–28.
- Fonti R, Del Vecchio S, Zannetti A, et al. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med. 2001; 28(2): 214–220.
- Fonti R, Pace L, Cerchione C, et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study. Clin Nucl Med. 2015; 40(4): 303–308.
